CA2868684A1 - Nanoparticle aggregates containing osteopontin and calcium-and/or strontium-containing particles - Google Patents

Nanoparticle aggregates containing osteopontin and calcium-and/or strontium-containing particles Download PDF

Info

Publication number
CA2868684A1
CA2868684A1 CA2868684A CA2868684A CA2868684A1 CA 2868684 A1 CA2868684 A1 CA 2868684A1 CA 2868684 A CA2868684 A CA 2868684A CA 2868684 A CA2868684 A CA 2868684A CA 2868684 A1 CA2868684 A1 CA 2868684A1
Authority
CA
Canada
Prior art keywords
nanoparticle aggregates
spp
opn
biofilm
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2868684A
Other languages
English (en)
French (fr)
Inventor
Henrik Birkedal
Jakob Olsen
Jonas SKOVGAARD
Sebastian SCHLAFER
Rikke Louise MEYER
Bente NYVAD
Duncan Stewart Sutherland
Peter Langborg WEJSE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Foods AMBA
Original Assignee
Arla Foods AMBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods AMBA filed Critical Arla Foods AMBA
Publication of CA2868684A1 publication Critical patent/CA2868684A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0275—Containing agglomerated particulates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
CA2868684A 2012-03-28 2013-03-27 Nanoparticle aggregates containing osteopontin and calcium-and/or strontium-containing particles Abandoned CA2868684A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12161802.9 2012-03-28
EP12161802 2012-03-28
PCT/EP2013/056598 WO2013144247A1 (en) 2012-03-28 2013-03-27 Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles

Publications (1)

Publication Number Publication Date
CA2868684A1 true CA2868684A1 (en) 2013-10-03

Family

ID=48141914

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2868684A Abandoned CA2868684A1 (en) 2012-03-28 2013-03-27 Nanoparticle aggregates containing osteopontin and calcium-and/or strontium-containing particles

Country Status (13)

Country Link
US (2) US20150044260A1 (cg-RX-API-DMAC7.html)
EP (1) EP2830647A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015516949A (cg-RX-API-DMAC7.html)
KR (1) KR20150004814A (cg-RX-API-DMAC7.html)
CN (1) CN104321073A (cg-RX-API-DMAC7.html)
AR (1) AR090569A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013241750A1 (cg-RX-API-DMAC7.html)
CA (1) CA2868684A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014002583A1 (cg-RX-API-DMAC7.html)
EA (1) EA201491691A1 (cg-RX-API-DMAC7.html)
MX (1) MX2014011594A (cg-RX-API-DMAC7.html)
NZ (1) NZ700295A (cg-RX-API-DMAC7.html)
WO (1) WO2013144247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US12109284B2 (en) 2016-11-08 2024-10-08 Dentherapy Ltd Compositions comprising fluoride and calcium and method for preparing them
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020197887A1 (en) * 2019-03-22 2020-10-01 The Board Of Regents Of The University Of Oklahoma Surface-modified doped titanium dioxide nanoparticles and uses
CN111366733B (zh) * 2020-03-07 2022-02-08 浙江大学 骨桥蛋白作为靶分子在调节肠道菌群定植中的应用
JPWO2021193398A1 (cg-RX-API-DMAC7.html) * 2020-03-27 2021-09-30
GB202010987D0 (en) 2020-07-16 2020-09-02 Dentherapy Ltd Oral care compositions and methods
GB202110114D0 (en) 2021-07-14 2021-08-25 Dentherapy Ltd Oral care compositions for use in treaatment
WO2023187028A1 (en) * 2022-03-31 2023-10-05 Nadavia Holding Aps Mouthwash composition comprising one or more strontium salt
WO2025008636A1 (en) 2023-07-06 2025-01-09 Dentherapy Ltd Oral care compositions for use in the treatment of dental health conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259243B2 (en) * 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
AU2004294673B2 (en) * 2003-12-01 2010-05-20 Arla Foods Amba Use of osteopontin in dental formulations
CA2632876A1 (en) * 2005-12-16 2007-06-21 Arla Foods Amba Bovine osteopontin formulations for the improvement of the wound healing process
WO2009010071A1 (en) * 2007-07-16 2009-01-22 Aarhus Universitet Osteopontin nanoparticles system for drug delivery
AU2012222312B2 (en) 2011-03-03 2017-06-08 Arla Foods Amba Method for isolating osteopontin using feeds containing cmp or casein species

Also Published As

Publication number Publication date
US20170065673A1 (en) 2017-03-09
CL2014002583A1 (es) 2015-06-12
AR090569A1 (es) 2014-11-19
CN104321073A (zh) 2015-01-28
EA201491691A1 (ru) 2015-04-30
KR20150004814A (ko) 2015-01-13
EP2830647A1 (en) 2015-02-04
MX2014011594A (es) 2015-07-06
AU2013241750A8 (en) 2014-10-23
NZ700295A (en) 2016-07-29
JP2015516949A (ja) 2015-06-18
US20150044260A1 (en) 2015-02-12
AU2013241750A1 (en) 2014-10-09
WO2013144247A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
US20170065673A1 (en) Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles
He et al. Polyzwitterion manipulates remineralization and antibiofilm functions against dental demineralization
JP7058344B2 (ja) 歯肉健康を促進するための口腔ケア組成物
JP7058343B2 (ja) 歯肉健康を促進するための口腔ケア組成物
Kovtun et al. Chlorhexidine-loaded calcium phosphate nanoparticles for dental maintenance treatment: combination of mineralising and antibacterial effects
JP7058342B2 (ja) 歯肉健康を促進するための口腔ケア組成物
Cordero et al. Li-doped bioglass® 45S5 for potential treatment of prevalent oral diseases
JP5973585B2 (ja) ラクトフェリン機能化表面を有する生体模倣ヒドロキシアパタイト粒子を含有するデンタルケア製品
Uskoković et al. Synthesis and characterization of nanoparticulate niobium-and zinc-doped bioglass-ceramic/chitosan hybrids for dental applications
Roveri et al. Recent advancements in preventing teeth health hazard: the daily use of hydroxyapatite instead of fluoride
BRPI0618143A2 (pt) uso de sais de cálcio dificilmente hidrossolúveis e/ou seus compósitos
RU2722306C1 (ru) Композиция для регуляции микроэлементного обмена в полости рта
Yan et al. In vitro evaluation of a novel fluoride-coated clear aligner with antibacterial and enamel remineralization abilities
WO2012036645A2 (en) Preparation method of an oral care gel containing eggshell powder
Babayevska et al. Novel nanosystems to enhance biological activity of hydroxyapatite against dental caries
Lu et al. Applications of photothermally mediated nanohybrids for white spot lesions in orthodontics
Xu et al. VMT/ACP/Dextran composite nanosheets against dental caries through promoting mineralization of dentin tubules, pH buffering, and antibacterial
Mu et al. Yellow light and ultrasound Dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization
KR101352795B1 (ko) 치아의 접합능을 향상시키기 위한 치과용 클린저 조성물
Helal et al. Comparing the remineralization potential of undemineralized dentin powder versus chicken eggshell powder on artificially induced initial enamel carious lesions: an in-vitro investigation
El-Gar et al. Potent antibacterial and antibiofilm activities of a synthetic remineralizing preparation of nano-hydroxyapatite against cariogenic Streptococcus mutans using an ex-vivo animal model
Tabari et al. The effect of silicone oil and nano-hydroxyapatite/chitosan powder on microhardness and surface structure of primary teeth enamel after iron drop consumption
CN105287244A (zh) 蒙脱石功能性牙膏及其制备方法
Shakir et al. Innovation of nano-hydrogels loaded with amelogenin peptide and hydroxyapatite nano-particles for remineralisation of artificially induced white spot lesions
DE102005052371A1 (de) Verwendung von schwer wasserlöslichen Calciumsalzen und/oder deren Kompositen

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180327